Haegarda
Ended Awarded
- Contract number
- 36C25820N0299
- Awardee
-
CSL Behring L.L.C. UEI H3WKVE9VBLY3
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $195,086
Award facts
- Contract value 100% obligated
- $195,086.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- King of Prussia, PA 19406, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award to CSL Behring L.L.C., doing business as CSL Behring LLC, is for the delivery of HAEGARDA, a drug used to treat Hereditary Angioedema, to the Department of Veterans Affairs (VA) Veterans Health Administration. The $195,086.00 firm fixed price award was made through the Pharmaceuticals and Drugs Federal Supply Schedule contract managed by the General Services Administration (GSA). The contract has no set-aside designation. This award is associated with a $17.5 million Blanket Purchase Agreement that allows VA facilities nationwide to procure HAEGARDA through September 2024. Orders have been issued by regional VA Integrated Service Networks, such as a $87,956 firm fixed price order from Network 22 for delivery to the VA Greater Los Angeles Healthcare System and a $113,280 order from Network 7 for deliveries from April through June 2023.
Quick answers
Who was awarded contract 36C25820N0299?
36C25820N0299 was awarded to CSL Behring L.L.C. by Veterans Integrated Service Network 22 (Veterans Health Administration) on June 30, 2020.
How much is contract 36C25820N0299 worth?
The government has obligated $195,086 on 36C25820N0299.
Is contract 36C25820N0299 an order under another contract?
Yes. 36C25820N0299 is a delivery order under V797D50358, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25820N0299 competed?
The extent of competition for 36C25820N0299 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award